Recruiting × Carcinoma, Renal Cell × Gynecologic × Clear all Keynote B59
Phase 1/2 Recruiting
317 enrolled
PNeoVCA
Phase 1/2 Recruiting
132 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 Recruiting
134 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
949 enrolled
DP-04
Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
BASECAMP-1
Recruiting
200 enrolled
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
250 enrolled
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Phase 1/2 Recruiting
124 enrolled
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Phase 1 Recruiting
43 enrolled
ELEPHAS-02
Recruiting
416 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
158 enrolled
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 Recruiting
130 enrolled
PSI-Immune
Phase 2 Recruiting
480 enrolled
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 Recruiting
90 enrolled
TraveraRTGx
Recruiting
200 enrolled
ORACLE
Recruiting
2,020 enrolled
ABILITY-1
Phase 1/2 Recruiting
115 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
30 enrolled
ADPORT-601
Phase 1/2 Recruiting
90 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours
Phase 1 Recruiting
40 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/2 Recruiting
125 enrolled
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
48 enrolled